欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2009, Vol. 14 ›› Issue (9): 1056-1060.

• 药物治疗学 • 上一篇    下一篇

清热化瘀滋阴方对系统性红斑狼疮外周血淋巴细胞凋亡及Fas、FasL基因表达的影响

梁卫, 金琳, 龚林, 张丽玲, 廖晖, 蔡鹰, 唐永明   

  1. 中国人民解放军第454 医院中医科, 南京210002, 江苏
  • 收稿日期:2009-06-30 修回日期:2009-09-21 发布日期:2020-11-03
  • 作者简介:梁卫, 女, 硕士研究生, 副主任医师, 研究方向:风湿免疫病。Tel:13851933380 E-mail:liangwei69 @163. com
  • 基金资助:
    南京军区“ 十一五” 攻关课题面上项目(06MA73)

Effects of Qingrehuayuziyin Fang on lymphocyte apoptosis and expression of Fas and FasL in peripheral blood in the patients with systemic lupus erythematosus

LIANG Wei, JIN lin, GONG Ling, ZHANG Li-ling, LIAO Hui, CAI Ying, TANG Yong-ming   

  1. Department of Traditional Medicine of No. 454 Hospital of PLA, Nanjing 210002, Jiangsu, China
  • Received:2009-06-30 Revised:2009-09-21 Published:2020-11-03

摘要: 目的: 探讨中药清热化瘀滋阴方对系统性红斑狼疮(SLE) 患者外周血淋巴细胞凋亡及Fas 、FasL 基因表达的影响。方法: 临床筛选SLE 患者80 例, 完全随机分为治疗组(清热化瘀滋阴方配合激素组) 和对照组(单用激素组) 各40 例, 服药3 个月, 淋巴细胞分离液分离治疗前后SLE 患者外周血淋巴细胞, 采用流式细胞仪检测淋巴细胞凋亡率;采用RT-PCR 法检测淋巴细胞Fas 、FasL基因表达情况。结果: 清热化瘀滋阴方治疗后SLE 患者外周血淋巴细胞凋亡率较治疗前明显下降(P <0.01), 并明显低于对照组(P <0.01) ;两组治疗后Fas 、FasL 基因的表达均明显下降, 治疗组Fas 基因的表达明显低于对照组(P <0.01) 。结论: 清热化瘀滋阴方可能通过降低SLE 患者外周血淋巴细胞凋亡率, 下调淋巴细胞Fas 、FasL 基因的表达水平, 改善免疫紊乱而发挥作用。

关键词: 清热化瘀滋阴方, 系统性红斑狼疮, 凋亡, Fas, FasL

Abstract: AIM: To investigate the effect of Qingrehuayuziyin Fang on lymphocyte apoptosis and expression of Fas and FasL in peripheral blood in the patients with systemic lupus erythematosus (SLE). METHODS: Eighty patients with SLE were selected and divided randomly into two groups, 40 in the therapy group and 40 in control group respectively. Patients were get the treatment of Qingrehuayuziyin Fang combined hormone (prednisone) as therapy group and get hormone treating only as control group. After treating three months, lymphocyte were collected to be detected the rate of apoptosis by flow cytometer. Meanwhile, the expression of Fas and FasL were analyzed by RT-PCR. RESULTS: After three months treating, the rate of lymphocyte apoptosis was decreased significantly in therapy group compared with that in control group(P < 0.01) and with that in pre-treating (P <0.01). The expression of Fas and FasL, compared with that in control group, was also decreased significantly (P < 0.01). CONCLUSION: Qingrehuayuziyin Fang is useful for treating SLE by suppressing lymphocyte apoptosis, decreasing the level of Fas and FasL in peripheral blood and further modifying the immune status.

Key words: Qingrehuayuziyin Fang, systemic lupus erythematosus, apoptosis, Fas, FasL

中图分类号: